XAU/USD4,699.34+0.28% BTC/USD77,811-0.76% ETH/USD2,321-0.29% SOL/USD186.34+0.43% EUR/USD1.0934+0.12% GBP/USD1.2641-0.08% USD/JPY153.42+0.22% AVAX/USD9.44+0.35% WTI78.21+1.04% DXY104.18-0.14% SPX5,812+0.31% NDX20,341+0.48% XAU/USD4,699.34+0.28% BTC/USD77,811-0.76% ETH/USD2,321-0.29% SOL/USD186.34+0.43% EUR/USD1.0934+0.12% GBP/USD1.2641-0.08% USD/JPY153.42+0.22% AVAX/USD9.44+0.35% WTI78.21+1.04% DXY104.18-0.14% SPX5,812+0.31% NDX20,341+0.48%

GULF 13H AGO Source: Menafn

U.S. Supreme Court Backs Hikma In Vascepa Patent Dispute

(MENAFN - Jordan News Agency) Amman, June 5 (Petra)-- The U.S. Supreme Court has ruled that Hikma Pharmaceuticals' generic version of the cardiovascular drug Vascepa does not infringe patents held ...

 (MENAFN - Jordan News Agency) Amman, June 5 (Petra)-- The U.S. Supreme Court has ruled that Hikma Pharmaceuticals' generic version of the cardiovascular drug Vascepa does not infringe patents held ... 

All news → Forex news Crypto news Economic calendar

Plan your next trade

Lot size calculator Risk calculator XAUUSD trading guide Risk management